SANDOZ ANAGRELIDE 0.5 MG
ANAGRELIDE (ANAGRELIDE HYDROCHLORIDE MONOHYDRATE) : 0.5 MG · DIN 02260107 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is SANDOZ ANAGRELIDE?
SANDOZ ANAGRELIDE 0.5 MG contains ANAGRELIDE (ANAGRELIDE HYDROCHLORIDE MONOHYDRATE) : 0.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02260107, held by SANDOZ CANADA INCORPORATED, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Feb-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SANDOZ ANAGRELIDE used for?
Treatment of patients with thrombocythemia secondary to myeloproliferative neoplasms to reduce elevated platelet count and risk of thrombosis and to ameliorate associated symptoms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02260107 |
|---|---|
| Brand name | SANDOZ ANAGRELIDE |
| Generic / active ingredient | ANAGRELIDE (ANAGRELIDE HYDROCHLORIDE MONOHYDRATE) : 0.5 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 0.5 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L01XX35 ANAGRELIDE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Feb-2020 |
How is it administered?
Starting dose: 0.5 mg q.i.d. or 1 mg b.i.d. for at least one week. Adjust by max 0.5 mg/day per week. Max dose: 10 mg/day or 2.5 mg in a single dose. Target platelet count < 600,000/mcL.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in the provided text (header present but content missing from snippet).
How is it supplied?
Not explicitly detailed in the provided text (mentions bottles of 100 in standard practice, but text only lists 'Dosage Forms, Composition and Packaging' as a header).
Contraindications
Hypersensitivity to the drug or any ingredient; severe hepatic impairment.
Warnings and precautions
Cardiovascular effects (tachycardia, palpitations, CHF, QTc prolongation); Pulmonary hypertension; Interstitial lung disease; Bleeding risk with ASA; Hepatic/Renal monitoring required.
What can be used instead?
Other Canadian products sharing ATC code L01XX35 ANAGRELIDE. 1 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-ANAGRELIDE | 0.5 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02274949 |
| AGRYLIN | 0.5 MG | CAPSULE | TAKEDA CANADA INC | CANCELLED POST MARKET | DIN 02236859 |
| DOM-ANAGRELIDE | 0.5 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02281287 |
| MYLAN-ANAGRELIDE | 0.5 MG | CAPSULE | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02253054 |
| PHL-ANAGRELIDE | 0.5 MG | CAPSULE | PHARMEL INC | CANCELLED POST MARKET | DIN 02281155 |
Who else supplies ANAGRELIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ANAGRELIDE appears in 40 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.